Roche Pharma España selected MicroStrategy to deliver mission-critical information on sales
and profitability to employees every day.
“Roche Pharma España was able to easily develop and deploy three business intelligence
applications on the MicroStrategy platform in record time, and we expect to deploy additional
BI applications in the coming months,” said Victor Martín, Chief Analyst of Information
Systems at Roche Pharma España. “The MicroStrategy platform offers Web-based query and
reporting capabilities, intuitive and rapid access to critical information, and personalizes and
distributes relevant information to all of our employees. The company’s outstanding services
and its commitment to perfecting its platform are additional reasons we chose to work
with MicroStrategy.”
A wide range of employees — including sales, marketing, production, and credit and collections
personnel — are using MicroStrategy technology to perform intuitive query and reporting
analysis against a SQL Server data warehouse. The solution provides Roche end users with
needed sales analysis, statistical information, and financial reports to more effectively manage
debt. Roche Pharma España is also relying on the MicroStrategy platform to proactively deliver
personalized information via Web, wireless, and voice to its employees and sales force.
Headquartered in Basel, Switzerland, Roche is one of the world’s leading research-focused healthcare
groups in the fields of pharmaceuticals and diagnostics. As the world’s biggest biotech company and
an innovator of products and services for the early detection, prevention, diagnosis, and treatment
of diseases, the Group contributes on a broad range of fronts to improving people’s health and quality
of life. Roche is the world leader in in-vitro diagnostics and drugs for cancer and transplantation,
a market leader in virology and active in other major therapeutic areas such as autoimmune diseases,
inflammation, metabolism, and central nervous system. In 2006, sales by the Pharmaceuticals Division
totaled 33.3 billion Swiss francs, and the Diagnostics Division posted sales of 8.7 billion Swiss francs.
Roche employs roughly 75,000 worldwide and has R&D agreements and strategic alliances with
numerous partners, including majority ownership interests in Genentech and Chugai.
Personalizing and Distributing Information to Over
1,000 Employees throughout Spain